TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has provided an announcement.
JOINN Laboratories (China) Co., Ltd. has established a Remuneration and Evaluation Committee to enhance its governance structure by managing remuneration and evaluation for its directors and senior management. This committee is tasked with formulating assessment standards, reviewing remuneration policies, and ensuring transparent procedures for developing remuneration strategies, which could strengthen the company’s operational efficiency and align management incentives with corporate goals.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates within the pharmaceutical and biotechnology industry, focusing on providing laboratory services and solutions. The company is primarily engaged in the evaluation and testing of pharmaceutical products, contributing to the development and safety assessment of new drugs.
Average Trading Volume: 6,769,040
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.27B
Learn more about 6127 stock on TipRanks’ Stock Analysis page.